4
Changes in Ownership
KYNTRA BIO, INC. Filed Acc 0001209191-23-018062
Chief Financial Officer sold 7,661 shares at an average $20.54 ($157,367)
- Chief Financial Officer acquired 7,567 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Graham Juan Chief Financial Officer | 2023-03-08 | Sale | −2,749 | $21.16 | $58,158 | 70,213 | D: show line 1 in the form |
| Graham Juan Chief Financial Officer | 2023-03-08 | Grant or award | +2,899 | 73,112 | D: show line 2 in the form | ||
| Graham Juan Chief Financial Officer | 2023-03-08 | Grant or award | +4,668 | 77,780 | D: show line 3 in the form | ||
| Graham Juan Chief Financial Officer | 2023-03-10 | Sale | −1,112 | $20.20 | $22,459 | 76,668 | D: show line 4 in the form |
| Graham Juan Chief Financial Officer | 2023-03-10 | Sale | −1,456 | $20.20 | $29,407 | 75,212 | D: show line 5 in the form |
| Graham Juan Chief Financial Officer | 2023-03-10 | Sale | −2,344 | $20.20 | $47,342 | 72,868 | D: show line 6 in the form |
| Open-market sales · 7,661 sh · avg $20.54 · $157,367 | |||||||
Loading xslF345X03/doc4.xml…